Posted by Michael Wonder on 17 Feb 2025
Cost sharing for preferred branded drugs in Medicare Part D
14 February 2025 - Most individuals in the US are concerned about prescription drug affordability.
For patients facing co-insurance (a percentage of the drug price), out-of-pocket burden increases when list prices increase, as they have for brand-name drugs over the last decade. Manufacturer rebates and discounts, which have also increased, reduce net drug prices but are rarely shared with patients at the pharmacy counter.
